Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis

S Neitemeier, A M Dolga, B Honrath, S S Karuppagounder, I Alim, R R Ratan, C Culmsee

Research output: Contribution to journalArticleAcademicpeer-review

26 Citations (Scopus)
236 Downloads (Pure)

Abstract

Mitochondrial impairment induced by oxidative stress is a main characteristic of intrinsic cell death pathways in neurons underlying the pathology of neurodegenerative diseases. Therefore, protection of mitochondrial integrity and function is emerging as a promising strategy to prevent neuronal damage. Here, we show that pharmacological inhibition of hypoxia-inducible factor prolyl-4-hydroxylases (HIF-PHDs) by adaptaquin inhibits lipid peroxidation and fully maintains mitochondrial function as indicated by restored mitochondrial membrane potential and ATP production, reduced formation of mitochondrial reactive oxygen species (ROS) and preserved mitochondrial respiration, thereby protecting neuronal HT-22 cells in a model of glutamate-induced oxytosis. Selective reduction of PHD1 protein using CRISPR/Cas9 technology also reduced both lipid peroxidation and mitochondrial impairment, and attenuated glutamate toxicity in the HT-22 cells. Regulation of activating transcription factor 4 (ATF4) expression levels and related target genes may mediate these beneficial effects. Overall, these results expose HIF-PHDs as promising targets to protect mitochondria and, thereby, neurons from oxidative cell death.

Original languageEnglish
Article numbere2214
Number of pages13
JournalCell death & disease
Volume7
DOIs
Publication statusPublished - 2016

Keywords

  • INDUCED OXIDATIVE STRESS
  • FOCAL CEREBRAL-ISCHEMIA
  • PROLYL-HYDROXYLASE
  • OXYGEN SENSOR
  • ALZHEIMERS-DISEASE
  • BRAIN-INJURY
  • IN-VIVO
  • HYPOXIA
  • NEUROPROTECTION
  • METABOLISM

Cite this